The murine mammary adenocarcinoma TS/A, growing in immunocompetent BALB/c mice, was used in vivo as tumor model where tumor cells do not express endoglin or ET, and therefore the effect of GET of plasmids silencing endoglin should be based on vascular targeted effects. The gene discussed is ENG; the disease is breast adenocarcinoma.